Overview

SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A mono centre study to evaluate the efficacy of SOM230 in patients with progressive metastatic or postoperative persistent medullary thyroid cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Federico II University
Treatments:
Everolimus
Pasireotide
Sirolimus